Abstract
AbstractPurpose: Validation of the new Postnatal Growth and Retinopathy of Prematurity (G‐ROP) criteria for screening of retinopathy of prematurity (ROP) in a Spanish tertiary care hospital with an advanced neonatal intensive care unit.Methods: Retrospective cohort study that includes premature infants with current ROP screening criteria (less than or equal to 32 weeks of gestational age and/or less than or equal to 1500 g of birth weight) born between January 2017 and December 2021 in a tertiary care hospital with an advanced neonatal intensive care unit. The compliance with the G‐ROP criteria was assessed for each patient, including: gestational age <28 weeks, birth weight <1051 g, weight gain <120 g during 10–19 days postnatal age, <180 g during 20–29 days, <170 g during 30–39 days or hydrocephalus. The objective was to determine specificity, sensitivity and reduction of patients examined with these new criteria.Results: Of 483 patients included (203 female and 280 male), the new G‐ROP criteria predicted 100% of cases of type 1 ROP (treatment‐requiring ROP) (15 of 15 cases) (Sensitivity 100%, Specificity 37.68%). Applying these criteria, there would be a reduction of 34.36% (166 patients) in infants requiring examination.Conclusions: This study observes that the new G‐ROP screening criteria may suppose an increase of sensitivity and specificity with a reduction of the number of infants requiring screening. However, other studies with a larger population would be necessary to verify the results.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.